FutureWiseResearch: Global Market Research Reports, USA, UK

Overview

Anti-infective Agents Market Overview:

According to FutureWise analysis the market for Anti-infective Agents is expected to register a CAGR of 3.40% from 2023-2031.

Anti-infective agents, also known as antimicrobial agents, are drugs that can either prevent or treat an infectious agent or inhibit it from spreading. Anti-infectives include antibacterials, antibiotics, antifungals, antivirals, and antiparasitic medications. Antibiotics specifically treat infections caused by bacteria. The most commonly used types of antibiotics are Aminoglycosides, Penicillins, Fluoroquinolones, Cephalosporins, Macrolides, and Tetracyclines. The development and use of anti-infective agents have revolutionized modern treatment by significantly reducing the morbidity and mortality associated with infectious diseases. New approaches, such as antibacterial peptides and photodynamic therapy (PDT), have been considered as alternatives to kill bacteria.

The selection of an appropriate dose of an anti-infective agent is based on the site of infection, identity and known or presumed antibiotic susceptibility of the infecting organism, dose-related drug toxicity, and the patient's ability to eliminate the drug. Typically, dosage selections from the higher end are recommended for severe, life-threatening infections (e.g., sepsis, meningitis). Known organisms with intermediate susceptibility (i.e., high minimal inhibitory concentration [MIC]) should also prompt higher dosages.

FutureWise Market Research has published a report that provides an insightful analysis anti-infective agents market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, anti-infective agents market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

Major players included in the Anti-infective Agents Market:

GlaxoSmithKline plc.
Pfizer, Inc
Bayer AG
Sanofi
MerckCo., Inc.
Bristol-Myers Squibb Company
Abbott
Novartis AG
Johnson & Johnson Services, Inc
Astellas Pharma Inc
Gilead Sciences, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Anti-infective Agents Market:

In Oct 2022- Merck expanded its vaccine manufacturing facility in Elkton, VA.
In June 2022- The US FDA approved Merck's VAXNEUVANCE drug for the prevention of invasive pneumococcal disease in infants and children.

Increasing awareness of infectious diseases among individuals is expected to drive the demand for anti-infective agents market over the projected period. Rising public awareness, often fueled by global health crises like the COVID-19 pandemic, propels individuals to seek timely medical intervention and preventive measures. This growing consciousness not only drives patient attention and demand for effective treatments but also fosters increased R&D investments, enabling the development of innovative anti-infective agents to address emerging and existing infectious disease challenges. For instance, in November 2021, the WHO performed the World Antimicrobial Awareness Week (WAAW) with the theme, ‘Spread Awareness, Stop Resistance’to raise awareness about antimicrobial resistance. Thus, these awareness initiatives boost the market growth. Furthermore, the limited understanding of these agents' altered pharmacokinetics within a specific population, including pediatrics, geriatrics, and patients with compromised immune systems, is anticipated to hinder the growth of the market during the projected period. This knowledge gap poses a challenge in determining appropriate dosage protocol, potential drug interactions, and safety profiles tailored to these diverse patient groups. As a result, delays in effective treatment strategies and the potential for side effects restrain market growth by impeding the development of accurate and optimized therapeutic approaches for these vulnerable populations. Moreover, the availability of alternative treatments and therapies in the market for patients and healthcare providers to explore is expected to restrain the market growth. Factors include concerns about the overuse of antibiotics, the desire for more unified approaches, and treatments with potentially fewer side effects. The growing interest in natural, complementary therapies and non-pharmacological interventions challenges the sustained market growth of conventional anti-infective agents. As patients and healthcare professionals seek diverse treatment options, the competition for these alternatives poses a risk to the established market share of traditional anti-infective agents.

Anti-infective Agents Market Segmentation:

By Type

Antibacterial
- Cephalosporins
- Penicillin
- Fluoroquinolones
- Macrolides
- Carbapenem
- Others
Antifungal
- Azoles
- Echinocandins
- Polyenes
- Others
Antiviral

By Route of Administration

Oral
Topical
IV

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Specialty Pharmacies
e-Commerce
Others

By Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Due to factors such as an advanced healthcare infrastructure, high awareness in society, well-established distribution channels, and a good presence of e-commerce across the United States, this is expected to drive the market over the forecast period in the area. The US Center for Disease Control and Prevention (CDC) advocates using antivirals for various infectious diseases. For instance, in September 2021, the CDC published a brochure supporting the use of antiviral drugs to treat influenza. The CDC suggested the use of four drugs approved by the FDA: oseltamivir phosphate, zanamivir, peramivir, and baloxavir marboxil. Such activities by governmental health organizations promoting antivirals in the nation are expected to propel the market's growth during the projected period in the region.

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the Anti-infective Agents Market By Type, By Route of Administration, By Distribution Channel and By Region.
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

1. Market Introduction
- 1. Objectives of the Study
  2. Market Definition
  3. Market Scope
  3.1 . Years Considered for the Study
  3.2 . Market Covered
  4. Currency
  5. Limitations
  6. Stakeholders
2. Research Methodology
- 1. Research Data
  1.1 . Secondary Data
  1.1.1 . Key Data from Secondary Sources
  1.2 . Primary Data
  1.2.1. Key Data from Primary Sources
  2. Market Size Estimation
  3. Market Breakdown and Data Triangulation
  4. Assumptions for the Study
3. Executive Summary
- 1. Market Outlook
  2. Segment Outlook
  3. Competitive Insights
4. Global Anti-infective Agents Market Variables, Trends and Scope
- 1. Market Lineage Outlook
  2. Penetration and Growth Prospect Mapping
  3. Industry Value Chain Analysis
  4. Cost Analysis Breakdown
  5. Technology Overview
  6. Regulatory Framework
  6.1. Reimbursement Framework
  6.2. Standards and Compliances
5. Market Overview
- 1. Market Dynamics
  1.1. Market Driver Analysis
  1.1.1. Increasing focus of Anti-infective Agents Companies on Brand Protection
  1.1.2. Untapped Opportunities in Emerging Regions
  1.2. Market Restraint Analysis
  1.2.1. High Cost Associated with Implementation of Predictive Analysis
  1.3. Industry Challenges
  1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Anti-infective Agents Market Analysis Tools
- 1. Industry Analysis - Porter’s
  1.1. Supplier Power
  1.2. Buyer Power
  1.3. Substitution Threat
  1.4. Threat from New Entrants
  1.5. Competitive Rivalry
  2. Pestel Analysis
  2.1. Political Landscape
  2.2. Environmental Landscape
  2.3. Social Landscape
  2.4. Technology Landscape
  2.5. Legal Landscape
  3. Major Deals And Strategic Alliances Analysis
  3.1. Joint Ventures
  3.2. Mergers and Acquisitions
  3.3. Licensing and Partnership
  3.4. Technology Collaborations
  3.5. Strategic Divestments
  4. Market Entry Strategies
  5. Case Studies
7. Global Anti-infective Agents Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Antibacterial
  1.1. Cephalosporins
  1.2. Penicillin
  1.3. Fluoroquinolones
  1.4. Macrolides
  1.5. Carbapenem
  1.6. Others
  2. Antifungal
  2.1. Azoles
  2.2. Echinocandins
  2.3. Polyenes
  2.4. Others
  3. Antiviral
8. Global Anti-infective Agents Market, By Route of Administration Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Oral
  2. Topical
  3. IV
9. Global Anti-infective Agents Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Specialty Pharmacies
  4. e-Commerce
  5. Others
10. North America Anti-infective Agents Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. U.S.A
  2.2. Canada
  2.3. Mexico
  3. Market Size (USD Million) Forecast for North America 2023-2031
11. Latin America Anti-infective Agents Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Brazil
  2.2. Venezuela
  2.3. Argentina
  2.4. Rest of Latin America
  3. Market Size (USD Million) Forecast for Latin America 2023-2031
12. Europe Anti-infective Agents Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Germany
  2.2. U.K
  2.3. France
  2.4. Italy
  2.5. Spain
  2.6. Russia
  2.7. Poland
  2.8. Rest of Europe
  3. Market Size (USD Million) Forecast for Europe 2023-2031
13. Asia Pacific Anti-infective Agents Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Japan
  2.2. China
  2.3. India
  2.4. Australia and New Zealand
  2.5. ASEAN
  2.6. Rest of Asia Pacific
  3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031
14. Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Saudi Arabia
  2.2. UAE
  2.3. South Africa
  2.4. Egypt
  3. Market Size (USD Million) Forecast for MEA 2023-2031
15. Market Share Analysis and Competitive Landscape
- 1. Global Landscape - Key Players, Revenue and Presence
  2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
  3. Global Emerging Companies
  4. North America - Market Share Analysis and Key Regional Players
  5. Europe - Market Share Analysis and Key Regional Players
  6. Asia Pacific - Market Share Analysis and Key Regional Players
  7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
- 1. GlaxoSmithKline plc.
  1.1. Company Overview
  1.2. Product Portfolio
  1.3. SWOT Analysis
  1.4. Financial Overview
  1.5. Strategic Overview
  2. Pfizer, Inc
  2.1. Company Overview
  2.2. Product Portfolio
  2.3. SWOT Analysis
  2.4. Financial Overview
  2.5. Strategic Overview
  3. Bayer AG
  3.1. Company Overview
  3.2. Product Portfolio
  3.3. SWOT Analysis
  3.4. Financial Overview
  3.5. Strategic Overview
  4. Sanofi
  4.1. Company Overview
  4.2. Product Portfolio
  4.3. SWOT Analysis
  4.4. Financial Overview
  4.5. Strategic Overview
  5. MerckCo., Inc.
  5.1. Company Overview
  5.2. Product Portfolio
  5.3. SWOT Analysis
  5.4. Financial Overview
  5.5. Strategic Overview
  6. Bristol-Myers Squibb Company
  6.1. Company Overview
  6.2. Product Portfolio
  6.3. SWOT Analysis
  6.4. Financial Overview
  6.5. Strategic Overview
  7. Abbott
  7.1. Company Overview
  7.2. Product Portfolio
  7.3. SWOT Analysis
  7.4. Financial Overview
  7.5. Strategic Overview
  8. Novartis AG
  8.1. Company Overview
  8.2. Product Portfolio
  8.3. SWOT Analysis
  8.4. Financial Overview
  8.5. Strategic Overview
  9. Johnson & Johnson Services, Inc
  9.1. Company Overview
  9.2. Product Portfolio
  9.3. SWOT Analysis
  9.4. Financial Overview
  9.5. Strategic Overview
  10.Astellas Pharma Inc
  10.1. Company Overview
  10.2. Product Portfolio
  10.3. SWOT Analysis
  10.4. Financial Overview
  10.5. Strategic Overview
  11.Gilead Sciences, Inc.
  11.1. Company Overview
  11.2. Product Portfolio
  11.3. SWOT Analysis
  11.4. Financial Overview
  11.5. Strategic Overview
17. Pre and Post COVID-19 Impact
- 1. Positive influence on the healthcare industry
  2. The financial disruption of the manufacturing sector
  3. Impact of COVID-19 on emerging companies
  4. Significant mandates in the healthcare regulations initiated by administrations
  5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client

Data Pack license: Data Pack license: $1250

Single user license: Single user license: $2850

Multi user license: Multi user license: $3850

Corporate license: Corporate license: $5000

Ask for Discount

Buy Now

Customize This Report

Partner

Report Overview

Table of Contents

List of Tables

List of figures

Overview

Table of Contents

Report Overview

Table of Contents

List of Tables

List of figures

Need Assistance

What you get

What's included

Our Clients